During the past decade, P3 Research Ltd conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "P3 Research Ltd" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "P3 Research Ltd" are "COVID-19" (2 trials), "Influenza" (1 trials), "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials), "Lower Respiratory Tract Disease" (1 trials) and "Respiratory Syncytial Viruses" (1 trials). Many other conditions were trialed in "P3 Research Ltd" in a lesser frequency.

Most popular intervention types in "P3 Research Ltd" are "Biological" (3 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials), "BNT162b2" (1 trials), "CIC Vaccine" (1 trials) and "ExPEC9V" (1 trials). Other intervention names were less common.

The vast majority of trials in "P3 Research Ltd" are 4 trials for "All" genders.

Currently, there are NaN active trials in "P3 Research Ltd". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in P3 Research Ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in P3 Research Ltd, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".